Retrospective price adjustment for Omeprazole 10mg/5ml and 20mg/5ml oral suspension SF and Melatonin 1mg/ml oral solution AF

Retrospective price adjustment for Omeprazole 10mg/5ml and 20mg/5ml oral suspension SF and Melatonin 1mg/ml oral solution AF

April 3, 2020

Omeprazole

Two Omeprazole licensed liquid preparations became available on the market in March 2020. Following representations from PSNC to account for the licensed products now on market, Department of Health and Social Care (DHSC) and the National Assembly of Wales have retrospectively determined from March 2020:

The addition of (with special container status applied):

  • Omeprazole 10mg/5ml oral suspension sugar free (75ml) to Category C based on Rosemont Pharmaceuticals Ltd, and
  • Omeprazole 20mg/5ml oral suspension sugar free (75ml) to Category C based on Rosemont Pharmaceuticals Ltd;

the deletion from Part VIIIB of:

  • Omeprazole 10mg/5ml oral suspension (STD, SF, LF, CF, NSF, FF, AF, BP)
  • Omeprazole 20mg/5ml oral suspension (STD, SF, LF, CF, NSF, FF, AF, BP)

Payment for March and April’s prescriptions will reflect the above retrospective determination and hence will not be as per the published Drug Tariff prices for March and April, respectively. Payments for Omeprazole 10mg/5ml oral suspension and Omeprazole 20mg/5ml oral suspension will be based on the licensed Omeprazole 10mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd) and Omeprazole 20mg/5ml oral suspension sugar free (Rosemont Pharmaceuticals Ltd), respectively.

Melatonin

In March 2020, Colonis Pharma relaunched Melatonin 1mg/ml oral solution sugar free (currently listed in Part VIIIA of the Drug Tariff) as an alcohol free formulation.

Following representation from PSNC to account for the reformulated product now on market, DHSC and the National Assembly of Wales have retrospectively determined from March 2020:

the deletion from Part VIIIB of:

  • Melatonin 5mg/5ml oral solution alcohol free
  • Melatonin 5mg/5ml oral suspension alcohol free

Payment for March and April’s prescriptions will reflect the above retrospective determination and hence will not be as per the published Drug Tariff prices for March and April, respectively. Payments for Melatonin 5mg/5ml oral solution alcohol free will be based on Melatonin 1mg/ml oral solution sugar free as listed in Part VIIIA of the Drug Tariff. Retrospective adjustment will not apply to prescriptions for Melatonin 5mg/5ml oral suspension alcohol free as this is a different formulation to the Melatonin 1mg/ml oral solution sugar free.



Posted in: ,


More Latest News >